Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases.

Bye, Lydia J; Finol-Urdaneta, Rocio K; Tae, Han-Shen; Adams, David J

Bye, Lydia J; Finol-Urdaneta, Rocio K; Tae, Han-Shen; Adams, David J.

Afiliación

Bye LJ; Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia.
Finol-Urdaneta RK; Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia.
Tae HS; Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia.
Adams DJ; Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia. Electronic address: djadams@uow.edu.au.

Int J Biochem Cell Biol ; 157: 106387, 2023 04.

Article en En | MEDLINE | ID: mdl-36754161

Asunto(s)

Enfermedades Neurodegenerativas; Enfermedad de Parkinson; Receptores Nicotínicos; Humanos; Receptores Nicotínicos/metabolismo; Enfermedades Neurodegenerativas/metabolismo; Enfermedades Neuroinflamatorias; Enfermedad de Parkinson/metabolismo; Colinérgicos; Microglía/metabolismo; Inflamación/metabolismo

Palabras clave

Inflammation; Microglia; Neurodegenerative diseases; Neuroinflammation; Nicotinic acetylcholine receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Receptores Nicotínicos / Enfermedades Neurodegenerativas Idioma: En Revista: Int J Biochem Cell Biol Asunto de la revista: BIOQUIMICA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google